These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
777 related items for PubMed ID: 17137666
1. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Geier MS, Butler RN, Howarth GS. Int J Food Microbiol; 2007 Apr 01; 115(1):1-11. PubMed ID: 17137666 [Abstract] [Full Text] [Related]
2. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C, Whelan K, Lindsay JO. Proc Nutr Soc; 2007 Aug 01; 66(3):307-15. PubMed ID: 17637082 [Abstract] [Full Text] [Related]
3. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Seksik P, Dray X, Sokol H, Marteau P. Mol Nutr Food Res; 2008 Aug 01; 52(8):906-12. PubMed ID: 18384087 [Abstract] [Full Text] [Related]
4. Prebiotics, synbiotics and inflammatory bowel disease. Steed H, Macfarlane GT, Macfarlane S. Mol Nutr Food Res; 2008 Aug 01; 52(8):898-905. PubMed ID: 18383235 [Abstract] [Full Text] [Related]
5. Gut microbiota and inflammatory bowel disease. Hammer HF. Dig Dis; 2011 Aug 01; 29(6):550-3. PubMed ID: 22179210 [Abstract] [Full Text] [Related]
6. Clinical usefulness of probiotics in inflammatory bowel diseases. Mach T. J Physiol Pharmacol; 2006 Nov 01; 57 Suppl 9():23-33. PubMed ID: 17242485 [Abstract] [Full Text] [Related]
7. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. Bosscher D, Breynaert A, Pieters L, Hermans N. J Physiol Pharmacol; 2009 Dec 01; 60 Suppl 6():5-11. PubMed ID: 20224145 [Abstract] [Full Text] [Related]
8. Probiotics, prebiotics, and synbiotics. de Vrese M, Schrezenmeir J. Adv Biochem Eng Biotechnol; 2008 Dec 01; 111():1-66. PubMed ID: 18461293 [Abstract] [Full Text] [Related]
9. [Probiotics for inflammatory bowel disease]. Iizuka H, Takaishi H, Hibi T. Nihon Rinsho; 2005 May 01; 63(5):776-80. PubMed ID: 15881169 [Abstract] [Full Text] [Related]
12. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Mitsuyama K, Sata M. Expert Opin Ther Targets; 2008 Mar 01; 12(3):301-12. PubMed ID: 18269340 [Abstract] [Full Text] [Related]